First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.29 USD 1.54% Market Closed
Updated: May 29, 2024

Aurinia Pharmaceuticals Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Other Equity Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Other Equity
-$854k
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
43%
Zymeworks Inc
NYSE:ZYME
Other Equity
-$6.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Other Equity
$744k
CAGR 3-Years
-42%
CAGR 5-Years
-30%
CAGR 10-Years
14%
Repare Therapeutics Inc
NASDAQ:RPTX
Other Equity
$28k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Other Equity
$237k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Other Equity
CA$10.5m
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
12%

See Also

What is Aurinia Pharmaceuticals Inc's Other Equity?
Other Equity
-854k USD

Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Other Equity amounts to -854k USD.

What is Aurinia Pharmaceuticals Inc's Other Equity growth rate?
Other Equity CAGR 10Y
43%

Over the last year, the Other Equity growth was 15%. The average annual Other Equity growth rates for Aurinia Pharmaceuticals Inc have been -2% over the past three years , -1% over the past five years , and 43% over the past ten years .